Janney Montgomery Scott’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
KWM
FCBT
EP
Janney Montgomery Scott's XPH Position: Q2 2026 in Review
Janney Montgomery Scott held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2026 at 4,245 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #2786.
Janney Montgomery Scott first reported a position in XPH in Q3 2018 and has held it in 19 quarters since. The position peaked at $1.74M in Q3 2018. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.
- Janney Montgomery Scott held 4,245 shares of State Street SPDR S&P Pharmaceuticals ETF worth $281K as of Q2 2026.
- Janney Montgomery Scott left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2786 holding.
- Janney Montgomery Scott first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2018 and has held it in 19 quarters since.
- Janney Montgomery Scott's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.74M in Q3 2018.
- 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.
Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.